Recent innovations in rectal cancer surgery emphasize precision, reduced invasiveness, and preservation of function. Minimally invasive techniques such as laparoscopic surgery, robotic-assisted surgery, and single-incision laparoscopic surgery (SILS) allow smaller incisions, less pain, faster recovery, and improved dexterity in confined pelvic spaces.
Organ- and function-preserving approaches, including transanal total mesorectal excision (TaTME), sphincter-sparing procedures, and nerve-sparing surgery, aim to remove tumors while maintaining urinary, sexual, and bowel function. Integration with neoadjuvant or adjuvant therapies, like watch-and-wait strategies for complete responders and intraoperative radiation therapy (IORT) for high-risk areas, further enhances treatment outcomes.
Enhanced visualization and guidance tools, such as fluorescence-guided surgery with indocyanine green (ICG) and augmented reality/3D imaging, help surgeons navigate complex anatomy and optimize resections. Combined with enhanced recovery protocols (ERAS) and AI-driven surgical planning, these innovations improve survival, reduce complications, and speed recovery, ultimately elevating quality of life for patients undergoing rectal cancer surgery.